BIT’s 10th World Congress of Regenerative Medicine & Stem Cells







About RMSC-2016

Following the great success of RMSC-2015, the 10th World Congress of Regenerative Medicine & Stem Cells-2016 (RMSC-2016) will be held during November 16-19, 2016, at Nanjing, China. With 7 Supporting Concurrent Conferences in Medical Chemistry, Drug Delivery, Cancer Immunotherapy, Microbes, Catalytic Asymmetric Synthesis, Microbes and Modern Chinese Medicine, as well as Variety Social Events, the conferences will attract 2000+ Participants from 80+ Countries with 500+ Poster and Exhibition Presentations to join in the grand festival!

RMSC-2016 as one Concurrent Conference of the Celebration Event will organize 90+ Parallel Sessions as well as Keynote Forum, and will approach 150+ Oral Presentations and 500+ Participants. You can enjoy other 8 concurrent conferences Free with Only One Registration Pass of RMSC!

Keynote and Renowned Speakers of RMSC-2016
Dr. Ken Kleinhenz, Vice President of Global Regulatory Affairs, Cytori Therapeutics, USA
Dr. Dave Smith, Vice President Global Business Development, Lonza, USA Dr. Stewart Washer, Executive Chairman, Cynata Theraputics Ltd., Australia
Dr. Sven Lee, Director, Global Sales & Business Development, Terumo BCT Inc., USA Dr. George F. Tidmarsh, President & Chief Executive Officer, La Jolla Pharmaceutical Company, USA Dr. Robert Hariri, Chairman and Founder, Celgene Cellular Therapeutics, USA
Dr. John R. Wetherell, Partner Co-Chair National Life Science Group, Pillsbury Winthrop Shaw Pittman LLP, USA  Dr. Meretzki Shai, Chairman, Biological Induatries, Israel Dr. Philippe HENON, President and CSO, CellProthera, France
Dr. Sicco Popma, Scientific Director, Janssen RD, USA Dr. Robert Chow, Founder, StemCyte Taiwan Co. Ltd., Taiwan Dr. Sergey Sikora, President and CEO, CardioCell, USA
Dr. Greg Maguire, CEO, BioRegenerative Sciences, Inc., USA Dr. Asit Panja, Chief Scientific Officer, AlfaGene Bioscience, USA Dr. Tom Barrows, Executive Vice President and CSO, Cell Constructs, Inc., USA
Dr. Francois Binette, Vice President of Research And Business Development, OrthoCyte Corporation, USA Dr. Jae-Ho Jeong, Director, Oblige Plastic Surgery, South Korea Dr. Gong Chen, Professor and Verne M. Willaman Chair in Life Science, Pennsylvania State University, USA
Dr. Dinender K. Singla, Professor, University of Central Florida, USA Dr. Richard P Harvey, Head of Developmental and Stem Cell Biology Laboratory, Victor Chang Cardiac Rsch Institute, Australia Dr. Jose R. Nunez, Professor, WHO, Switzerland
Dr. Hugo Vankelecom, Professor, University of Leuven, Belgium Dr. Tero Jarvinen, Professor & Chief Surgeon, University of Tampere and Tampere University Hospital, Finland Dr. Pradeep Srivastava, Professor, Indian Institute of Technology-IIT, Banaras Hindu University, India
Dr. Jean-Marc lemaitre, Director, Functional Genomics Institute, INSERM U1183, France Dr. Shaoguang Li, Professor, University of Massachusetts Medical School, USA Dr. Xuefen Le Bourhis, Professor, Inserm U908, Batiment SN3, Université Lille 1, France
Dr. Robert Rees, Professor of Tumour Biology, School of Science and Technology, Nottingham Trent University, UK Dr. Antonio Apicella, Full Professor and Chair, Second University of Naples, Italy Dr. Mark Bradley, Professor, Edinburgh University, UK
Dr. Gianni Soldati, President, Swiss Stem Cell foundation, Switzerland Dr. Yang (Ted) Teng, Professor/Director, Harvard University, USA Dr. Joseph Purita, Director, The Institute of Regenerative and Orthopedic Medicine, USA
Dr. Duanqing Pei, Professor and Director General, Guangzhou Institute of Biomedicine  Health, CAS, China Dr. Nabil Dib, Professor of Medicine, University of Arizona College of Medicine-Phoenix, USA 说明: 765 Dr. Arnold Caplan, Chief Scientific Officer, OrthoCyte Corp., USA
说明: C:\Users\zhangxinjian\Desktop\Deepak Puri.png Dr. Deepak Puri, Director, Fortis Hospital Mohali, USA Dr. Maxwell Wang, Director of Medical Research, Cellular Biomedicine Group, Inc., USA Dr. Bumsup Lee, Vice President and CSO, Kolon Life Science Inc., Korea
Mr. Gerald Commissiong, President & CEO,, Amarantus Bioscience Holdings, Inc. USA Dr. Joan Mannick, Executive Director, Translational Medicine, Novartis Institutes for BioMedical Research, USA Dr. Amy Jiyeon White, Vice President, Business Development, Asia Pacific Region, Stemedica Cell Technologies, Inc., USA
Dr. Lei Wang, Doctor and PI, Shanghai Jiao Tong University School of Medicine,
Shanghai Key Laboratory of Stomatology, China
Dr. Joel Aronowitz, Plastic Surgeon and Founder, the University Stem Cell Center in Los Angeles, USA Dr. Sen Pathak, Professor, University of Texas M.D. Anderson Cancer Center, USA
Dr. Oscar Kuang-Sheng Lee, Editor-in-Chief, The World Journal of Stem Cells, Taiwan Dr. Juan Merlo, Professor, Lund University, Sweden Dr. Kibret Mequanint, Professor, University of Western Ontario, Canada
Dr. Jianguo Cheng, Professor, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, USA Dr. Larry F. Lemanski, Distinguished Research Professor, Texas A&M University-Commerce, USA Dr. Thomas Ritter, Professor, Regenerative Medicine Institute, Ireland
Dr. Richard Funk, Professor & Chair of Anatomy, University of Technology Dresden, Germany Dr. Ruipeng Jia, Director and Professor, Nanjing First Hospital, Nanjing Medical University, China Dr. George A. Truskey, Professor, Duke University, USA
Main Conference
Part 1: Opening Ceremony

Part 3: Plenary LecturesChallenges and Opportunities in Stem Cell Industry - Innovation Todays Securing Health Tomorrow
Part 2: Keynote Forum
-Next Big Things in Regenerative Medicine & Stem Cell Bio-economy

Part 4: Global Strategy, Assessment, Policy, Regulatory, Ethic, Limits and Challenges
Business and Career Growth Workshop
Session 1: Project Roadshow
Session 3: Overseas Chinese Entrepreneurship Round Table
Session 2: Funding, Market Trend and Business
Session 4: Career Development Forum
Exhibition & Posters
As part of the RMSC-2016 Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.
Exhibitors' advantages
• Meet with International Leaders and Senior Officers in the Field of Advanced Materials.
• Maximize Your Opportunities for Collaboration
• Explore Business Opportunities in China and beyond
• Spotlight Your Technologies and Its Commercial Application
• Superior Networking Opportunities with Senior Professionals and Industry Elites
   Poster Date:
Set-up date: November 15, 2016
Show dates: 09:00-18:00, November 16-19, 2016
Place: Nanjing, China
Social Activities
Business Development, Talent Exchange, Social & Cultural Activities
Industrial Promotion, Appoint People by Abilities, Culture Agglomeration
Topic 1: Euro-America Stem Cell Partnership
Topic 2: Asia Stem Cell Collaboration
Topic 3: Overseas Chinese Entrepreneurship in RM
Topic 4: Joint Events with the Regional Organizations
Event 1: Welcome Banquet and Art Performance
Event 2: Field Trip Industry Park/Universities
Event 3: Industrial Sponsored Cocktail Party
Event 4: Culture Tour in Nanjing
News Release

Scientific Program of RMSC-2016 Released!
Early Bird Registration!
Abstract Submission is Open!
Speaking and Program Proposal are Welcomed Now!
Website of RMSC-2016 Released!

Hosting Organization

Information Research Center of International Talent, SAFEA

Jiangsu Pharmaceutical Association

Operating Organization

BIT Group Global Ltd.
Foreign Experts Databank of SAFEA-Dalian Branch

Official Travel Agency
Media Partners
BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2015-2016 BIT Group Global Ltd.